SUCROSOMIAL TECHNOLOGY

A unique delivery system, a revolution in the field of nutraceuticals, which guarantees maximum efficacy in transporting and absorbing essential bioactive compounds.

CETYLATED FATTY ACIDS

A patented solution designed to enhance joint and muscle mobility, known for its exceptional skin penetration and rapid absorption.

PRODUCTS

PharmaNutra products are designed to provide a safe and effective response to health and well-being requirements at any stage of life.
R&D

We are committed to advancing nutraceutical science by developing effective, high-quality supplements and medical devices.

In our laboratories, we use cutting-edge research models to drive innovation, blending solid scientific methods with a forward-thinking approach to technology and patents. PharmaNutra's research focuses on key health areas, especially addressing nutritional deficiencies in minerals and vitamins, supporting muscle and joint health and enhancing functional and sports nutrition.

MORE
THERAPEUTIC AREAS

Our scientific research

NEWS

Inform, innovate, inspire: putting health first

Stay updated with the latest from PharmaNutra: scientific insights, events, groundbreaking products and updates tailored to support your professional practice.
Intranet

CPHI Milan 2024: PharmaNutra presents for the first time its new Sucrosomial® Vitamins

Read more
Raw materials

Bioenergy Ribose: support for sportspeople’s energy

Read more
News & Events

Cetilar Villorba Corse at the Bologna Motor Show

Read more
News & Events

Cetilar Villorba Corse first tests for the 24 Hours of Le Mans 2018

Read more
Raw materials

Atura plant origin proteins: Alesco signs the distribution agreement

Read more
Raw materials

UltraJoint: what it is and how it helps to maintain cartilage and joint health 

Read more
Senza categoria

PharmaNutra obtains patent for a new composition for treating cardiovascular diseases

Read more
News & Events

Cetilar® at Cariparma Running

Read more
Raw materials

UltraD3®: the first vitamin D3 with Sucrosomial® Technology

Read more
Iron deficiency

SiderAL® and vegetarian and vegan diet

Read more
Iron deficiency

New areas of application recognised for Sucrosomial® Iron

Read more
Raw materials

News 2021: Sucrosomial® Berberine and Sucrosomial® Chromium

Read more
Raw materials

Alesco-PharmaNutra Merger: from July 2024, Alesco will become a business division of the Group

Read more
News & Events

CPHI Worldwide 2023: PharmaNutra ready to present business and scientific innovations to foreign markets

Read more
News & Events

Cetilar® and Obiettivo 3 together towards Tokyo 2020

Read more